Cargando…

Who benefits from diagnostic labels for developmental disorders?

The number of diagnoses of developmental disorders is on the rise and the use of labels for developmental disorders, such as attention‐deficit/hyperactivity disorder and autism spectrum disorder, is widening. Diagnostic labels can play an important role in helping those who display atypical behaviou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werkhoven, Sander, Anderson, Joel H., Robeyns, Ingrid A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306602/ https://www.ncbi.nlm.nih.gov/pubmed/35191027 http://dx.doi.org/10.1111/dmcn.15177

Ejemplares similares

Is Procreation Special?
por: Robeyns, Ingrid
Publicado: (2021)

Diagnostic and prognostic benefit of arterial spin labeling in subacute stroke
por: Thamm, Thoralf, et al.
Publicado: (2019)

Development of the uncinate fasciculus: Implications for theory and developmental disorders
por: Olson, Ingrid R., et al.
Publicado: (2015)

Early Enteral Feeding in Preterm Infants: A Narrative Review of the Nutritional, Metabolic, and Developmental Benefits
por: Thoene, Melissa, et al.
Publicado: (2021)

Transient Fluorescence Labeling: Low Affinity—High Benefits
por: Perfilov, Maxim M., et al.
Publicado: (2021)

The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders
por: Delanne, Julian, et al.
Publicado: (2021)

The various methods and benefits of denture labeling
por: Datta, Pankaj, et al.
Publicado: (2010)

The diagnostic trajectory of developmental coordination disorder in the Netherlands: Experiences of mothers
por: Lust, Jessica M., et al.
Publicado: (2021)

Lipid-lowering therapy: who can benefit?
por: Lewis, Sandra J
Publicado: (2011)

Cancer Markers. Diagnostic and Developmental Significance
por: Moore, M.
Publicado: (1981)

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
por: Yao, Liqin, et al.
Publicado: (2022)

Who will benefit more from maintenance therapy of metastatic colorectal cancer?
por: Zhou, Mingyi, et al.
Publicado: (2017)

Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy
por: Jan, I-Shiow, et al.
Publicado: (2023)

Potential Benefits of Ameliorating Metabolic and Nutritional Abnormalities in People With Profound Developmental Disabilities
por: Glick, Norris R, et al.
Publicado: (2017)

Complex Diagnostics of Non-Specific Intellectual Developmental Disorder
por: Levchenko, Olga, et al.
Publicado: (2022)

Diagnostic value of partial exome sequencing in developmental disorders
por: Gieldon, Laura, et al.
Publicado: (2018)

PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study
por: Woo, Young Sup, et al.
Publicado: (2016)

Health and Reference Classes
por: Werkhoven, Sander
Publicado: (2020)

Stress in Caregivers and Children with a Developmental Disorder Who Receive Rehabilitation
por: Kim, Sung Hyun, et al.
Publicado: (2020)

Development of the WHO Caregiver Skills Training Program for Developmental Disorders or Delays
por: Salomone, Erica, et al.
Publicado: (2019)

A serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most?
por: Bul, Kim C. M., et al.
Publicado: (2018)

Who pays for and who benefits from health care services in Uganda?
por: Kwesiga, Brendan, et al.
Publicado: (2015)

Extracellular Vesicles in CNS Developmental Disorders
por: Gomes, Ana Rita, et al.
Publicado: (2020)

Developmental Language Disorder: Early Predictors, Age for the Diagnosis, and Diagnostic Tools. A Scoping Review
por: Sansavini, Alessandra, et al.
Publicado: (2021)

Who benefits most?
por: Van Diermen, L.
Publicado: (2021)

Toward An Understanding of Developmental Coordination Disorder: Terminological and Diagnostic Issues
por: Henderson, Sheila E., et al.
Publicado: (2003)

Correction: Diagnostic value of partial exome sequencing in developmental disorders
por: Gieldon, Laura, et al.
Publicado: (2020)

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
por: Huber, Elizabeth, et al.
Publicado: (2016)

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?
por: Olde Nordkamp, L. R. A., et al.
Publicado: (2013)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

Who Will Benefit from Charged-Particle Therapy?
por: Kim, Kyung Su, et al.
Publicado: (2021)

Who benefits from voter identification laws?
por: Harden, Jeffrey J., et al.
Publicado: (2023)

Non-diagnostic based approaches to helping children who could be labelled ADHD and their families
por: Timimi, Sami
Publicado: (2017)

Who benefits from government expenditure? : a case study of Colombia /
por: Selowsky, Marcelo
Publicado: (1979)

Maternal Obesity and Developmental Programming of Metabolic Disorders in Offspring: Evidence from Animal Models
por: Li, M., et al.
Publicado: (2011)

Characteristics of students who require elementary school counselors’ support owing to developmental disorders
por: Hirata, Yutaro, et al.
Publicado: (2023)

Alcoholics Anonymous: Who Benefits?
por: Tonigan, J. Scott, et al.
Publicado: (1994)

Pre-implantation genetic testing in ART: who will benefit and what is the evidence?
por: Vaiarelli, Alberto, et al.
Publicado: (2016)

Adjustable Versus Nonadjustable Sutures in Strabismus Surgery—Who Benefits the Most?
por: Gawęcki, Maciej
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jfgsdh1hjj93aem5uik0taq17m